Hilary Marston
Hilary Marston, M.D., M.P.H., is the Chief Medical Officer (CMO) of the FDA. The CMO is the primary clinical advisor to the Commissioner and oversees the Office of Clinical Policy and Programs (OCPP). In this capacity, the CMO leads programs and cross-cutting initiatives that support the FDA’s centers in making effective, safe, and innovative medical products available to the American people.
×
Americas
-
Rear Admiral Richardae Araojo •
-
Robyn Bent, MS, RN •
-
Kevin Bugin •
-
Namandjé Bumpus •
-
Ashley Boam, MS •
-
Diane Bruce, PharmD, RAC •
-
Suranjan De •
-
Michelle Campbell •
-
Ethan Chen •
-
John Concato •
-
Jacqueline Corrigan-Curay, JD, MD •
-
Christy Cottrell •
-
Selena Daniels, PharmD, PhD, MS •
-
Khair ElZarrad •
-
Ron Fitzmartin, PhD, MBA •
-
Dionna Green •
-
Richard Forshee, PhD •
-
Andrea Fristedt •
-
Cheryl Grandinetti, PharmD •
-
Karen Hicks •
-
Sarah Ibrahim •
-
Xianghong (Emily) Jing •
-
Michael Kopcha, PhD, RPh •
-
Jung Lee •
-
Claudia Manzo •
-
Peter Marks •
-
Janet Maynard •
-
Hilary Marston •
-
Ann Meeker-O'Connell, MS •
-
Monica Morell, PhD •
-
Tina Morrison •
-
Theresa Mullin, PhD •
-
Monica Munoz •
-
Iilun Murphy •
-
Martha Nguyen •
-
Steven Oh, PhD •
-
Lee Pai-Scherf •
-
Y. Veronica Pei •
-
Ana Pineda Zavaleta, MSc •
-
Andrew Potter •
-
Dionne Price, PhD •
-
Scott Proestel, MD •
-
Francisca Reyes-Turcu •
-
Stacey Ricci •
-
Leyla Sahin •
-
Norman Robert Schmuff, PhD •
-
Kimberly Schultz, PhD •
-
Haley Seymour, MS •
-
Mary Ann Slack •
-
Peter Stein •
-
Mary Thanh Hai, MD •
-
Julia Tierney •
-
Melissa Torres •
-
Stelios Tsinontides •
-
Katherine Tyner •
-
John Weiner, JD •
-
Celia Witten •